These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 10730908)

  • 1. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
    Sigurgeirsson B; Billstein S; Rantanen T; Ruzicka T; di Fonzo E; Vermeer BJ; Goodfield MJ; Evans EG
    Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
    Evans EG; Sigurgeirsson B
    BMJ; 1999 Apr; 318(7190):1031-5. PubMed ID: 10205099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
    Jansen R; Redekop WK; Rutten FF
    Pharmacoeconomics; 2001; 19(4):401-10. PubMed ID: 11383756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day--a double-blind comparative trial.
    De Backer M; De Keyser P; De Vroey C; Lesaffre E
    Br J Dermatol; 1996 Jun; 134 Suppl 46():16-7: discussion 38. PubMed ID: 8763462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
    Sigurgeirsson B; Olafsson JH; Steinsson JB; Paul C; Billstein S; Evans EG
    Arch Dermatol; 2002 Mar; 138(3):353-7. PubMed ID: 11902986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
    De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes in the treatment of toenail onychomycosis.
    De Cuyper C; Hindryckx PH
    Br J Dermatol; 1999 Nov; 141 Suppl 56():15-20. PubMed ID: 10730909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group.
    Bräutigam M; Nolting S; Schopf RE; Weidinger G
    BMJ; 1995 Oct; 311(7010):919-22. PubMed ID: 7580551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
    Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
    J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis.
    Salo H; Pekurinen M
    Pharmacoeconomics; 2002; 20(5):319-24. PubMed ID: 11994041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
    Kejda J
    Postgrad Med; 1999 Jul; Spec No():12-5. PubMed ID: 10492661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial.
    Yadav P; Singal A; Pandhi D; Das S
    Indian J Dermatol Venereol Leprol; 2015; 81(4):363-9. PubMed ID: 26087080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
    Gupta AK; Lynch LE; Kogan N; Cooper EA
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):256-62. PubMed ID: 19438818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrences of dermatophyte toenail onychomycosis during long-term follow-up after successful treatments with mono- and combined therapy of terbinafine and itraconazole.
    Gupta AK; Cooper EA; Paquet M
    J Cutan Med Surg; 2013; 17(3):201-6. PubMed ID: 23673304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis.
    Gupta AK; Stec N; Bamimore MA; Foley KA; Shear NH; Piguet V
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):580-588. PubMed ID: 31746067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbinafine: a review of its use in onychomycosis in adults.
    Darkes MJ; Scott LJ; Goa KL
    Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.